ILUVIEN patient case study library Phakic Eye Treatment Burden Managing IOP Vitrectomized Case 3 years of Iluvien Phakic “This phakic patient with cataracts was concerned about frequent injections for her DME. I chose ILUVIEN for this patient and her edema improved, and after cataract surgery she is seeing great.” — Daniel M. Miller, MD, PhD Results presented below are from a single case; results may vary. Daniel M. Miller, MD, PhD Board-certified Diplomate of the American Board of Ophthalmology and fellowship-trained retina specialist; Dr. Miller serves as the Medical Director of the Cincinnati Eye Institute. Academic affiliations: MD/PhD at the Ohio State University College of Medicine — graduated with recognition for academic excellence and national awards for his research contributions Internship at Riverside Methodist Hospital in Columbus, Ohio Ophthalmology residency and subspecialty training at the Bascom Palmer Eye Institute associated with the University of Miami School of Medicine Patient profile 1 Sex: Female Age: 68 Diagnosis: DME Treated eye: OD Concomitant conditions: High blood pressure Treatment history: • 2X Focal laser • 14X Anti-VEGF • 1X Corticosteroid Notes: Phakic to pseudophakic Reasons Dr. Miller chose ILUVIEN: Multiple prior lasers and intravitreal injections without consistent control of swelling in the macula Patient concern about frequent injections and results that were not optimal Looking for a longer-acting treatment option Patient outcome No additional treatments for DME were required during nearly 1 year of follow-up post ILUVIEN Visual acuity has improved Good changes in optical coherence tomography (OCT) “Since the patient’s ILUVIEN treatment, she has been extremely pleased, her visits are far less frequent than before ILUVIEN, and she does quite well with her vision.” — Daniel M. Miller, MD, PhD Retinal thickness (μm) Best corrected visual acuity (BCVA) Intraocular pressure (IOP) (mm Hg) Selected OCT Scans Baseline ILUVIEN injected Visual Acuity: 20/30 Letters: 76 OCT: 511 μm IOP: 16 mm Hg After treatment with ILUVIEN 2 months after Visual Acuity: 20/30 Letters: 76 OCT: 292 um IOP: 20 mm HG 1/4 4 months after Visual Acuity: 20/25 Letters: 80 OCT: 288 um IOP: 18 mm HG 2/4 7 months after Note: Statues change: phakic to pseudophakic Visual Acuity: 20/40 Letters: 70 OCT: 317 um IOP: 14 mm HG 3/4 10 months after Visual Acuity: 20/25 Letters: 80 OCT: 294 um IOP: 17 mm HG 4/4 Phakic CaseDownload a printable, pdf version of this case. DOWNLOADPhakic DataReview data from phakic patients in the ILUVIEN Phase 3 clinical trials (FAME). Learn More